An assessment of quality of life among stroke survivors at tertiary care teaching hospital in South India: A randomized clinical trial

Abstract

Abstract The study's primary aim was to examine how a stroke affects health‐related quality of life (QoL), and a secondary aim was to link this event with clinical and sociodemographic factors. Stroke patients were included in the study. First, 94 patients underwent a quantitative analytical cross‐sectional study 3 months after starting medication. Using multivariable linear regression, relationships between the severity of the initial stroke were investigated. From the raw data, we determined the standard deviation and the standard error of the mean. If the p‐value is less than .05, it is considered significant, and if it's less than .0001, it is extremely significant. The majority 94.68% were diagnosed with ischemic stroke, and only 5.32% were hemorrhagic stroke; 56.32% of the patients were male, and 43.68% were female; one‐third of the patients were found to be smokers and alcoholics; 9.57% of the patients had a family history of stroke; and 9.5% of the patients had a history of stroke. Patients with stroke comorbidities, including high blood pressure 88.19%, diabetes 51.06%, high cholesterol 22.34%, coronary artery disease 23.40%, smoking 30.85%, and alcoholism 24.46%. Significant dangers were posed by both hypertension and smoking. There was a statistically significant improvement in quality of life between the two groups, with the intervention group showing a mean difference of 112. The p‐value for this improvement was less than .0001. The quality of life of stroke survivors can be improved through direct screening, monitoring of the patient, planned therapy, and management.

Keywords

• antiplatelet
• intervention group
• neuroprotective drugs
• quality of life
• stroke survivors